Assessing sarcoidosis activity: Is serum chitotriosidase a reliable marker? Study of 430 patients and 264 healthy controls

V. Vucinic-Mihailovic, Z. Sumarac, D. Jovanovic, S. Filipovic, J. Videnovic-Ivanov, B. Gvozdenovic (Beograd, Republic Of Serbia)

Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Session: Pathogenetic mechanisms in pulmonary fibrosis
Session type: Oral Presentation
Number: 1735
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Vucinic-Mihailovic, Z. Sumarac, D. Jovanovic, S. Filipovic, J. Videnovic-Ivanov, B. Gvozdenovic (Beograd, Republic Of Serbia). Assessing sarcoidosis activity: Is serum chitotriosidase a reliable marker? Study of 430 patients and 264 healthy controls. Eur Respir J 2014; 44: Suppl. 58, 1735

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 5
Year: 2014

Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients
Source: International Congress 2014 – Sarcoidosis
Year: 2014

Does the BTNL2 genotype influence the course of disease in Danish sarcoidosis patients?
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014

Seasonal variation of serum KL-6 levels in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 1
Year: 2014

Serum levels of sestrin 2 in patients with sarcoidosis
Source: International Congress 2014 – ILDs 6
Year: 2014


Clinical features and prognosis of 108 patients with lymphangioleiomyomatosis
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014

Treatment of IPF with inhaled IFN-gamma; planning for a clinical trial
Source: International Congress 2014 – ILDs 3
Year: 2014


Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
Source: International Congress 2014 – IPF and surroundings
Year: 2014



Mutation alone does not predict the clinical course of surfactant protein C deficiency in children
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

Serum procalcitonin is useful in differentiating between drug-induced pneumonitis and bacterial pneumonia
Source: International Congress 2014 – ILDs 5
Year: 2014


Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia
Source: International Congress 2014 – ILDs 3
Year: 2014

Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 2
Year: 2014

Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome
Source: International Congress 2014 – ILDs 2
Year: 2014

European pulmonary alveolar proteinosis network (EuPAPNet): Results from biomarkers´ investigation
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014

Mindfulness-based stress reduction in patients with interstitial lung disease: A pilot study
Source: International Congress 2014 – ILDs 3
Year: 2014

Pregnancy course in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014


Impact of smoking habit on lung function in a large cohort sarcoidosis patients.
Source: International Congress 2014 – Sarcoidosis
Year: 2014

Cystic lung disease with pulmonary amyloidosis: Analysis of 21 patients
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Six-minute-walk test parameters in the prognostic evaluation of fibrotic lung diseases
Source: International Congress 2014 – ILDs 4
Year: 2014